ELI LILLY & Co — Director's Dealing 2018

May 31, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2018-05-29

Reporting Person: Shaw Christi (SVP and Pres., Lilly Bio-Meds)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-05-29	Common Stock	S	8426	$82.10	Disposed	0	Direct